Health
Large study of treatments for childhood type 2 diabetes launched
NEWS IN BRIEF — Posted April 5, 2004
The National Institute of Diabetes and Digestive and Kidney Diseases in March launched a large-scale study to hunt for the best treatments for type 2 diabetes in children and teens.
The study, titled Treatment Options for type 2 Diabetes in Adolescents and Youth -- TODAY -- will recruit those ages 10 to 17 who have had a diagnosis for at least two years. All participants at the 12 research centers around the country will receive metformin. Some will be randomized to receive either rosiglitazone or intensive lifestyle changes as well.
Adults with type 2 diabetes have many long-established treatment options. Younger people, a population that has only recently started developing the disease in great numbers, do not have as many established options. The hope is that this trial will answer questions about medication safety and efficacy in this age group as well as determining which lifestyle interventions are most useful.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2004/04/05/hlbf0405.htm.
